The Drugs Don’t Work
Summary
Antimicrobial resistance makes infections harder to treat and contributes to infant deaths in sub-Saharan Africa. Efforts to address it include low-cost care, research in the United Kingdom, and local innovation in Africa.Key Facts
- Antimicrobial resistance is linked to infant mortality in sub-Saharan Africa.
- Health workers and families in the region face challenges treating infections.
- Penicillin is examined as a major antibiotic discovery.
- Pharmaceutical companies, including GlaxoSmithKline, face challenges developing new treatments for antimicrobial resistance.
- Academic researchers at British universities and hospitals are studying antimicrobial resistance.
- DeepMind, a UK-based technology company, supports some research efforts.
- Local innovation and tools from developed countries are being used to help save lives in Africa.
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.